Histone Deacetylase 6 Market, Global Outlook and Forecast 2022-2028

Histone Deacetylase 6 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281510 | No. of Pages: 71 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Histone Deacetylase 6 in global, including the following market information:
Global Histone Deacetylase 6 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Histone Deacetylase 6 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Histone Deacetylase 6 companies in 2021 (%)
The global Histone Deacetylase 6 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Citarinostat Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Histone Deacetylase 6 include Celgene Corp, Chong Kun Dang Pharmaceutical Corp, Curis Inc, HitGen LTD, Kancera AB, Karus Therapeutics Ltd, Medivir AB, Merck & Co Inc and Millennium Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Histone Deacetylase 6 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Histone Deacetylase 6 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Histone Deacetylase 6 Market Segment Percentages, by Type, 2021 (%)
    Citarinostat
    CKD-504
    ACY-738
    HG-3001
    MPT-0B291
    Ricolinostat
    Others
Global Histone Deacetylase 6 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Histone Deacetylase 6 Market Segment Percentages, by Application, 2021 (%)
    CNS Lymphoma
    Colon Cancer
    Huntington Disease
    Inflammation
    Others
Global Histone Deacetylase 6 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Histone Deacetylase 6 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Histone Deacetylase 6 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Histone Deacetylase 6 revenues share in global market, 2021 (%)
Key companies Histone Deacetylase 6 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Histone Deacetylase 6 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Celgene Corp
    Chong Kun Dang Pharmaceutical Corp
    Curis Inc
    HitGen LTD
    Kancera AB
    Karus Therapeutics Ltd
    Medivir AB
    Merck & Co Inc
    Millennium Pharmaceuticals Inc
    OnKure Inc
    Quimatryx SL
    Shuttle Pharmaceuticals LLC
    Sigma-Tau SpA
    SK Biopharmaceuticals Co Ltd
1 Introduction to Research & Analysis Reports
    1.1 Histone Deacetylase 6 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Histone Deacetylase 6 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Histone Deacetylase 6 Overall Market Size
    2.1 Global Histone Deacetylase 6 Market Size: 2021 VS 2028
    2.2 Global Histone Deacetylase 6 Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Histone Deacetylase 6 Sales: 2017-2028
3 Company Landscape
    3.1 Top Histone Deacetylase 6 Players in Global Market
    3.2 Top Global Histone Deacetylase 6 Companies Ranked by Revenue
    3.3 Global Histone Deacetylase 6 Revenue by Companies
    3.4 Global Histone Deacetylase 6 Sales by Companies
    3.5 Global Histone Deacetylase 6 Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Histone Deacetylase 6 Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Histone Deacetylase 6 Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Histone Deacetylase 6 Players in Global Market
        3.8.1 List of Global Tier 1 Histone Deacetylase 6 Companies
        3.8.2 List of Global Tier 2 and Tier 3 Histone Deacetylase 6 Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Histone Deacetylase 6 Market Size Markets, 2021 & 2028
        4.1.2 Citarinostat
        4.1.3 CKD-504
        4.1.4 ACY-738
        4.1.5 HG-3001
        4.1.6 MPT-0B291
        4.1.7 Ricolinostat
        4.1.8 Others
    4.2 By Type - Global Histone Deacetylase 6 Revenue & Forecasts
        4.2.1 By Type - Global Histone Deacetylase 6 Revenue, 2017-2022
        4.2.2 By Type - Global Histone Deacetylase 6 Revenue, 2023-2028
        4.2.3 By Type - Global Histone Deacetylase 6 Revenue Market Share, 2017-2028
    4.3 By Type - Global Histone Deacetylase 6 Sales & Forecasts
        4.3.1 By Type - Global Histone Deacetylase 6 Sales, 2017-2022
        4.3.2 By Type - Global Histone Deacetylase 6 Sales, 2023-2028
        4.3.3 By Type - Global Histone Deacetylase 6 Sales Market Share, 2017-2028
    4.4 By Type - Global Histone Deacetylase 6 Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Histone Deacetylase 6 Market Size, 2021 & 2028
        5.1.2 CNS Lymphoma
        5.1.3 Colon Cancer
        5.1.4 Huntington Disease
        5.1.5 Inflammation
        5.1.6 Others
    5.2 By Application - Global Histone Deacetylase 6 Revenue & Forecasts
        5.2.1 By Application - Global Histone Deacetylase 6 Revenue, 2017-2022
        5.2.2 By Application - Global Histone Deacetylase 6 Revenue, 2023-2028
        5.2.3 By Application - Global Histone Deacetylase 6 Revenue Market Share, 2017-2028
    5.3 By Application - Global Histone Deacetylase 6 Sales & Forecasts
        5.3.1 By Application - Global Histone Deacetylase 6 Sales, 2017-2022
        5.3.2 By Application - Global Histone Deacetylase 6 Sales, 2023-2028
        5.3.3 By Application - Global Histone Deacetylase 6 Sales Market Share, 2017-2028
    5.4 By Application - Global Histone Deacetylase 6 Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Histone Deacetylase 6 Market Size, 2021 & 2028
    6.2 By Region - Global Histone Deacetylase 6 Revenue & Forecasts
        6.2.1 By Region - Global Histone Deacetylase 6 Revenue, 2017-2022
        6.2.2 By Region - Global Histone Deacetylase 6 Revenue, 2023-2028
        6.2.3 By Region - Global Histone Deacetylase 6 Revenue Market Share, 2017-2028
    6.3 By Region - Global Histone Deacetylase 6 Sales & Forecasts
        6.3.1 By Region - Global Histone Deacetylase 6 Sales, 2017-2022
        6.3.2 By Region - Global Histone Deacetylase 6 Sales, 2023-2028
        6.3.3 By Region - Global Histone Deacetylase 6 Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Histone Deacetylase 6 Revenue, 2017-2028
        6.4.2 By Country - North America Histone Deacetylase 6 Sales, 2017-2028
        6.4.3 US Histone Deacetylase 6 Market Size, 2017-2028
        6.4.4 Canada Histone Deacetylase 6 Market Size, 2017-2028
        6.4.5 Mexico Histone Deacetylase 6 Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Histone Deacetylase 6 Revenue, 2017-2028
        6.5.2 By Country - Europe Histone Deacetylase 6 Sales, 2017-2028
        6.5.3 Germany Histone Deacetylase 6 Market Size, 2017-2028
        6.5.4 France Histone Deacetylase 6 Market Size, 2017-2028
        6.5.5 U.K. Histone Deacetylase 6 Market Size, 2017-2028
        6.5.6 Italy Histone Deacetylase 6 Market Size, 2017-2028
        6.5.7 Russia Histone Deacetylase 6 Market Size, 2017-2028
        6.5.8 Nordic Countries Histone Deacetylase 6 Market Size, 2017-2028
        6.5.9 Benelux Histone Deacetylase 6 Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Histone Deacetylase 6 Revenue, 2017-2028
        6.6.2 By Region - Asia Histone Deacetylase 6 Sales, 2017-2028
        6.6.3 China Histone Deacetylase 6 Market Size, 2017-2028
        6.6.4 Japan Histone Deacetylase 6 Market Size, 2017-2028
        6.6.5 South Korea Histone Deacetylase 6 Market Size, 2017-2028
        6.6.6 Southeast Asia Histone Deacetylase 6 Market Size, 2017-2028
        6.6.7 India Histone Deacetylase 6 Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Histone Deacetylase 6 Revenue, 2017-2028
        6.7.2 By Country - South America Histone Deacetylase 6 Sales, 2017-2028
        6.7.3 Brazil Histone Deacetylase 6 Market Size, 2017-2028
        6.7.4 Argentina Histone Deacetylase 6 Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Histone Deacetylase 6 Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Histone Deacetylase 6 Sales, 2017-2028
        6.8.3 Turkey Histone Deacetylase 6 Market Size, 2017-2028
        6.8.4 Israel Histone Deacetylase 6 Market Size, 2017-2028
        6.8.5 Saudi Arabia Histone Deacetylase 6 Market Size, 2017-2028
        6.8.6 UAE Histone Deacetylase 6 Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Celgene Corp
        7.1.1 Celgene Corp Corporate Summary
        7.1.2 Celgene Corp Business Overview
        7.1.3 Celgene Corp Histone Deacetylase 6 Major Product Offerings
        7.1.4 Celgene Corp Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.1.5 Celgene Corp Key News
    7.2 Chong Kun Dang Pharmaceutical Corp
        7.2.1 Chong Kun Dang Pharmaceutical Corp Corporate Summary
        7.2.2 Chong Kun Dang Pharmaceutical Corp Business Overview
        7.2.3 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Major Product Offerings
        7.2.4 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.2.5 Chong Kun Dang Pharmaceutical Corp Key News
    7.3 Curis Inc
        7.3.1 Curis Inc Corporate Summary
        7.3.2 Curis Inc Business Overview
        7.3.3 Curis Inc Histone Deacetylase 6 Major Product Offerings
        7.3.4 Curis Inc Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.3.5 Curis Inc Key News
    7.4 HitGen LTD
        7.4.1 HitGen LTD Corporate Summary
        7.4.2 HitGen LTD Business Overview
        7.4.3 HitGen LTD Histone Deacetylase 6 Major Product Offerings
        7.4.4 HitGen LTD Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.4.5 HitGen LTD Key News
    7.5 Kancera AB
        7.5.1 Kancera AB Corporate Summary
        7.5.2 Kancera AB Business Overview
        7.5.3 Kancera AB Histone Deacetylase 6 Major Product Offerings
        7.5.4 Kancera AB Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.5.5 Kancera AB Key News
    7.6 Karus Therapeutics Ltd
        7.6.1 Karus Therapeutics Ltd Corporate Summary
        7.6.2 Karus Therapeutics Ltd Business Overview
        7.6.3 Karus Therapeutics Ltd Histone Deacetylase 6 Major Product Offerings
        7.6.4 Karus Therapeutics Ltd Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.6.5 Karus Therapeutics Ltd Key News
    7.7 Medivir AB
        7.7.1 Medivir AB Corporate Summary
        7.7.2 Medivir AB Business Overview
        7.7.3 Medivir AB Histone Deacetylase 6 Major Product Offerings
        7.7.4 Medivir AB Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.7.5 Medivir AB Key News
    7.8 Merck & Co Inc
        7.8.1 Merck & Co Inc Corporate Summary
        7.8.2 Merck & Co Inc Business Overview
        7.8.3 Merck & Co Inc Histone Deacetylase 6 Major Product Offerings
        7.8.4 Merck & Co Inc Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.8.5 Merck & Co Inc Key News
    7.9 Millennium Pharmaceuticals Inc
        7.9.1 Millennium Pharmaceuticals Inc Corporate Summary
        7.9.2 Millennium Pharmaceuticals Inc Business Overview
        7.9.3 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Major Product Offerings
        7.9.4 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.9.5 Millennium Pharmaceuticals Inc Key News
    7.10 OnKure Inc
        7.10.1 OnKure Inc Corporate Summary
        7.10.2 OnKure Inc Business Overview
        7.10.3 OnKure Inc Histone Deacetylase 6 Major Product Offerings
        7.10.4 OnKure Inc Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.10.5 OnKure Inc Key News
    7.11 Quimatryx SL
        7.11.1 Quimatryx SL Corporate Summary
        7.11.2 Quimatryx SL Histone Deacetylase 6 Business Overview
        7.11.3 Quimatryx SL Histone Deacetylase 6 Major Product Offerings
        7.11.4 Quimatryx SL Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.11.5 Quimatryx SL Key News
    7.12 Shuttle Pharmaceuticals LLC
        7.12.1 Shuttle Pharmaceuticals LLC Corporate Summary
        7.12.2 Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Business Overview
        7.12.3 Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Major Product Offerings
        7.12.4 Shuttle Pharmaceuticals LLC Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.12.5 Shuttle Pharmaceuticals LLC Key News
    7.13 Sigma-Tau SpA
        7.13.1 Sigma-Tau SpA Corporate Summary
        7.13.2 Sigma-Tau SpA Histone Deacetylase 6 Business Overview
        7.13.3 Sigma-Tau SpA Histone Deacetylase 6 Major Product Offerings
        7.13.4 Sigma-Tau SpA Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.13.5 Sigma-Tau SpA Key News
    7.14 SK Biopharmaceuticals Co Ltd
        7.14.1 SK Biopharmaceuticals Co Ltd Corporate Summary
        7.14.2 SK Biopharmaceuticals Co Ltd Business Overview
        7.14.3 SK Biopharmaceuticals Co Ltd Histone Deacetylase 6 Major Product Offerings
        7.14.4 SK Biopharmaceuticals Co Ltd Histone Deacetylase 6 Sales and Revenue in Global (2017-2022)
        7.14.5 SK Biopharmaceuticals Co Ltd Key News
8 Global Histone Deacetylase 6 Production Capacity, Analysis
    8.1 Global Histone Deacetylase 6 Production Capacity, 2017-2028
    8.2 Histone Deacetylase 6 Production Capacity of Key Manufacturers in Global Market
    8.3 Global Histone Deacetylase 6 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Histone Deacetylase 6 Supply Chain Analysis
    10.1 Histone Deacetylase 6 Industry Value Chain
    10.2 Histone Deacetylase 6 Upstream Market
    10.3 Histone Deacetylase 6 Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Histone Deacetylase 6 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com